Syracuse, NY — A cutting-edge cancer treatment that promises to control certain tumors after traditional methods fail is poised to reach more people in Central New York. Hematology-Oncology Associates of CNY is now scheduling roughly one patient a week to begin bispecific antibody therapy, a treatment for some cancers that have stopped responding to chemotherapy and radiation.